The Changing Face of CHS
CHS may not be diagnosed, however, because heavy users of cannabis tend to minimize that when questioned by the doctor.
Select Page
by C. Scott McMillin | Sep 10, 2026 | Addiction | 0 |
CHS may not be diagnosed, however, because heavy users of cannabis tend to minimize that when questioned by the doctor.
by C. Scott McMillin | Jun 25, 2026 | Public Policy | 0 |
by C. Scott McMillin | Jun 11, 2026 | Addictive Substances | 0 |
by C. Scott McMillin | Dec 18, 2025 | Addictive Substances | 0 |
by C. Scott McMillin | May 26, 2025 | Addictive Substances | 0 |
by C. Scott McMillin | Oct 28, 2024 | Addiction Clinicians | 0 |
by C. Scott McMillin | Aug 12, 2024 | Addictive Substances | 0 |
…the outcome can be serious. In some cases, we’re told, untreated lesions have led to amputation.
Read Moreby C. Scott McMillin | May 16, 2024 | Addictive Substances | 0 |
…the numbers are almost certain to rise. The combination of greater availability and increasing use of extra-high THC content products makes that conclusion inescapable.
Read Moreby C. Scott McMillin | Apr 4, 2024 | Addiction, Public Health | 0 |
ALD (alcohol-related liver disease) in the United States is projected to cost $355 billion in direct healthcare-related costs and $525 billion in lost labor and economic consumption.
Read Moreby C. Scott McMillin | Mar 25, 2024 | Addiction | 0 |
I suppose none of her staff or colleagues thought of seeking professional help. An intervention, for instance. Or perhaps they considered it but decided it was not their place to interfere. Maybe they were scared of her reaction. People around the drinker often are.
Read Moreby C. Scott McMillin | Dec 11, 2023 | Addictive Substances | 0 |
P2P has two advantages over traditional ephedrine-based meth, from the perspective of a cartel. First, as a true synthetic, there’s no natural upper limit on how much can be produced. Second, the P2P form is extremely cheap, both to make and sell.
Read Moreby C. Scott McMillin | Nov 9, 2023 | Addictive Substances | 0 |
Once again based on experience, I’m confident that many of the folks who will try psilocybin in future, because of all the favorable publicity, will fall into those ‘excluded’ categories.
Read Moreby C. Scott McMillin | Jun 15, 2023 | Addictive Substances | 0 |
From a treatment perspective, our goal has to be to provide patients with accurate information about cannabis use and its associated risks, so that their decisions will be informed ones.
Read Moreby C. Scott McMillin | Apr 24, 2023 | Addictive Substances, In the News | 0 |
When the trip ends, the writer acknowledges, the user may be “…throwing up or having trouble at the other end.”
Read Moreby C. Scott McMillin | Jan 16, 2023 | Addictive Substances | 0 |
Since so many millions of people use cannabis – long the world’s most widely used illicit drug — and the population of users is rising fast, it’s a legitimate cause for concern.
Read Moreby C. Scott McMillin | Dec 12, 2022 | Resources | 0 |
If someone was sick enough at some point to have been hospitalized for treatment of an SUD, they’re statistically more likely to suffer from other diseases later in life.
Read Moreby C. Scott McMillin | Oct 27, 2022 | Recovery | 0 |
Not an unusual path for the disease to take. That year of deliberate abstention indicates that Perry was aware that his problems were growing worse.
Read Moreby C. Scott McMillin | Mar 7, 2022 | Addictive Substances | 0 |
One common symptom of withdrawal is sleep disruption, for which the most direct remedy is, naturally, more of the drug.
Read More